|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online December 12, 2006
doi: 10.1242/10.1242/dev.02703
Research Report |

1 Developmental Skin Biology Unit, NIAMS, NIH, Bethesda, MD 20892, USA.
2 Department of Biomolecular and Biotechnological Sciences, University of Milan,
Via Celoria 26. 20133, Milan, Italy.
3 Dulbecco Telethon Institute c/o Istituto Tecnologie Biomediche CNR, 20100
Milan, Italy.
4 Department of Dermatology, University of Rome `Tor Vergata', Viale Oxford 81.
00133 Rome, Italy.
5 Division of Monoclonal Antibodies, CDER/FDA, Bethesda, MD 20892, USA.
6 Department of Structural and Functional Biology, University of Naples, Via
Cinzia 26. 80126 Naples, Italy.
Author for correspondence (e-mail:
morassom{at}mail.nih.gov)
Accepted 18 October 2006
SUMMARY
Ectodermal dysplasias (EDs) are a group of human pathological conditions
characterized by anomalies in organs derived from epithelial-mesenchymal
interactions during development. Dlx3 and p63 act as part of the
transcriptional regulatory pathways relevant in ectoderm derivatives, and
autosomal mutations in either of these genes are associated with human EDs.
However, the functional relationship between both proteins is unknown. Here,
we demonstrate that Dlx3 is a downstream target of p63. Moreover, we
show that transcription of Dlx3 is abrogated by mutations in the
sterile
-motif (SAM) domain of p63 that are associated with
ankyloblepharon-ectodermal dysplasia-clefting (AEC) dysplasias, but not by
mutations found in ectrodactylyectodermal dysplasia-cleft lip/palate (EEC),
Limb-mammary syndrome (LMS) and split hand-foot malformation (SHFM)
dysplasias. Our results unravel aspects of the transcriptional cascade of
events that contribute to ectoderm development and pathogenesis associated
with p63 mutations.
Key words: Dlx3, p63, Transcription, Ectodermal dysplasias, Mouse development
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
A. Sandilands, C. Sutherland, A. D. Irvine, and W. H. I. McLean Filaggrin in the frontline: role in skin barrier function and disease J. Cell Sci., May 1, 2009; 122(9): 1285 - 1294. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hwang, T. Mehrani, S. E. Millar, and M. I. Morasso Dlx3 is a crucial regulator of hair follicle differentiation and cycling Development, September 15, 2008; 135(18): 3149 - 3159. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-K. Lee, Z.H. Lee, S.-J. Lee, B.-D. Ahn, Y.-J. Kim, S.-H. Lee, and J.-W. Kim DLX3 Mutation in a New Family and Its Phenotypic Variations Journal of Dental Research, April 1, 2008; 87(4): 354 - 357. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Lo Iacono, S. Mantero, A. Chiarelli, E. Garcia, A. A. Mills, M. I. Morasso, A. Costanzo, G. Levi, L. Guerrini, and G. R. Merlo Regulation of Dlx5 and Dlx6 gene expression by p63 is involved in EEC and SHFM congenital limb defects Development, April 1, 2008; 135(7): 1377 - 1388. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shimomura, M. Wajid, L. Shapiro, and A. M. Christiano P-cadherin is a p63 target gene with a crucial role in the developing human limb bud and hair follicle Development, February 15, 2008; 135(4): 743 - 753. [Abstract] [Full Text] [PDF] |
||||